Skip to content

Comparison of the Effectiveness of Microneedling Therapy with CO2 Fractional Leaser therapy for theTreatment of Striae Distensa in Patients with Striae Distensae

Comparison of the Effectiveness of Microneedling Therapy with CO2 Fractional Leaser therapy for theTreatment of Striae Distensa in Patients with Striae Distensae

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20120909010795N5
Enrollment
40
Registered
2021-05-31
Start date
2019-04-07
Completion date
Unknown
Last updated
2021-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Striae rubra- striae alba. Linear dermal scars accompanied by epidermal atrophy that affects skin that is subjected to continuous streching. They usually do not cause any significant medical problems, only cosmetic problems.

Interventions

Intervention 1: Intervention group 1: It will be treated with microneedling method on a monthly basis. Intervention 2: Intervention group 2: It will be treated with fractional CO2 laser method on a mo

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 50 Years

Inclusion criteria

Inclusion criteria: Patients older than 15 and less than 50 years Patients with striae including striae alba and striae rubra on abdomen, buttock, and flank lesions Patients had not received previous treatment for striae distance in the last two months

Exclusion criteria

Exclusion criteria: Pregnant women breastfeeding mothers Patients taking immunosuppressive drugs Patients who are prone to forming keloid Patients who have received previous treatment for SD in the past 2 months Patients with Cushing's Syndrome or connective tissue diseases Patients who have vitamin derivatives A used up to 2 months prior to the study Patients who had a history of systemic or topical steroid use, filler injection, abdominal dermabrasion, or laser skin resurfacing in the striae distance area for the past 6–12 months Patients who had striae on their chest or arm Patients with defective blood supply or diabetes mellitus or wound healing disorders

Design outcomes

Primary

MeasureTime frame
Dermatologist assessed improvement score. Timepoint: At baseline and 1 and 6 months after treatment. Method of measurement: Photography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarzaneh Rahimi

Shiraz University of Medical Sciences

raahimi.1365@gmail.com+98 71 3235 2559

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026